Trevan Fischer, MD FACS (@drtrevanfischer) 's Twitter Profile
Trevan Fischer, MD FACS

@drtrevanfischer

Surgical Oncologist Serving Santa Monica, CA

ID: 920780347800895490

linkhttp://www.drtrevanfischer.com calendar_today18-10-2017 22:35:17

422 Tweet

172 Followers

165 Following

Trevan Fischer, MD FACS (@drtrevanfischer) 's Twitter Profile Photo

It’s been a few years since I’ve attended SoCal Chapter - American College of Surgeons chapter meeting. I’m excited to see some friends and colleagues that I tend to only see at meetings even though we live in the same city! #SCCACS2023

Trevan Fischer, MD FACS (@drtrevanfischer) 's Twitter Profile Photo

Thanks Farin Amersi for your vision on setting up this invited lecture! So many of us, in all levels of training and practice, need to hear it! #sccacs2023

Thanks <a href="/FarinAmersi/">Farin Amersi</a> for your vision on setting up this invited lecture! So many of us, in all levels of training and practice, need to hear it! #sccacs2023
Omid Hamid MD (@omidhamidmd) 's Twitter Profile Photo

Congrats Sapna Patel SWOG Cancer Research Network Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma NEJM setting a standard and paradigm shifting in all solid tumors nejm.org/doi/full/10.10…

Congrats <a href="/DrSapnaPatel/">Sapna Patel</a> <a href="/SWOG/">SWOG Cancer Research Network</a> Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma <a href="/NEJM/">NEJM</a> setting a standard and paradigm shifting in all solid tumors nejm.org/doi/full/10.10…
Elad Sharon (@eladsharonmd) 's Twitter Profile Photo

This @swog trial (S1512) from National Cancer Institute is the highest response rate for a single agent PD1 inhibitor in the metastatic/unresectable setting for a solid tumor! 89% response with a third of patients with a complete response! Remarkable!!! #DesmoplasticMelanoma

This @swog trial (S1512) from <a href="/theNCI/">National Cancer Institute</a> is the highest response rate for a single agent PD1 inhibitor in the metastatic/unresectable setting for a solid tumor! 89% response with a third of patients with a complete response! Remarkable!!! #DesmoplasticMelanoma